EGCG attenuated hepatocytes damage and dysfunction in NAFLD by alleviating FGF21 resistance and improve FGFR/AMPK pathway, mitigating oxidative stress. Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.